Proto Labs Inc
For the period ended Jun 30, 2024. Filed Aug 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 2, 2024
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-03-31; filed 2024-05-03.
0001628280-24-020233
Item 1A. Risk Factors2. Unregistered Sales of Equity Securities and Use of Proceeds3. Defaults Upon Senior Securities4. Mine Safety DisclosuresCurrent report: 10-Q
Period ended 2024-06-30; filed 2024-08-02.
0001628280-24-034354
Item 1A. Risk Factors2. Unregistered Sales of Equity Securities and Use of Proceeds3. Defaults Upon Senior Securities4. Mine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 5 previous paragraphs and 5 current paragraphs.
3 unchanged; 2 reworded; 0 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Reworded paragraphs (2)
Previous wording
On February 7, 2023 our board of directors approved a new stock repurchase program that added $50 million to our previous stock repurchase authorization, which increased the total stock repurchase authorized to $250 million. We have $72.4 million remaining under this authorization. The timing and amount of any share repurchases will be determined by our management based on market conditions and other factors.
Current wording
On February 7, 2023 our board of directors approved a new stock repurchase program that added $50 million to our previous stock repurchase authorization, which increased the total stock repurchase authorized to $250 million. We have $61.4 million remaining under this authorization. The timing and amount of any share repurchases will be determined by our management based on market conditions and other factors.
Previous wording
During the three months ended March 31, 2024, we repurchased 435,861 shares of our common stock at a total purchase price of $16.0 million under this program. Common stock repurchase activity through March 31, 2024 was as follows:
Current wording
During the three months ended June 30, 2024, we repurchased 345,234 shares of our common stock at a total purchase price of $10.9 million under this program. Common stock repurchase activity through June 30, 2024 was as follows: